• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EXPRESS LD ILIAC / BILIARY; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EXPRESS LD ILIAC / BILIARY; STENT, ILIAC Back to Search Results
Model Number 20226
Medical Device Problem Codes Difficult to Advance (2920); Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 05/15/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Age at time of event: 18 years or older.
 
Event or Problem Description
It was reported that stent dislodgement occurred.The target lesion was located in the subclavian artery.A 9.0x30x135 cm express ld iliac / biliary stent was advanced; however, while advancing through a guide catheter, resistance was encountered and the stent detached with the balloon.The device was removed and the procedure was completed with another of the same device.No patient complications were reported and the patient's status was stable.
 
Additional Manufacturer Narrative
Age at time of event: 18 years or older.Device evaluated by mfr: the balloon was noted to be tightly folded and had not been subjected to positive pressure.A visual and microscopic examination identified no issues with the balloon material that could have contributed to the complaint incident.The device was returned with the stent mounted on to the balloon.A visual and microscopic examination identified that the stent had been moved approximately 10mm distally on the balloon.Both distal and proximal stent struts were noted to be lifted.No other issues were identified with the stent that could potentially have contributed to the complaint incident.A visual and microscopic examination identified no issues with the tip of the device during analysis that could have contributed to the complaint incident.A visual and tactile examination of the shaft identified no damage or any issues along the length of the device.The dfu states that this device is indicated for the treatment of atherosclerotic lesions found in iliac arteries up to 100 mm in length, with a reference diameter of 6 mm to 10 mm.The complaint device was used to treat the subclavian.
 
Event or Problem Description
It was reported that stent dislodgement occurred.The target lesion was located in the subclavian artery.A 9.0x30x135 cm express ld iliac / biliary stent was advanced; however, while advancing through a guide catheter, resistance was encountered and the stent detached with the balloon.The device was removed and the procedure was completed with another of the same device.No patient complications were reported and the patient's status was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXPRESS LD ILIAC / BILIARY
Common Device Name
STENT, ILIAC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8650299
Report Number2134265-2019-06001
Device Sequence Number16653888
Product Code NIO
UDI-Device Identifier08714729392491
UDI-Public08714729392491
Combination Product (Y/N)N
Initial Reporter CountryTW
PMA/510(K) Number
K133110
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,distri
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/01/2021
Device Model Number20226
Device Catalogue Number20226
Device Lot Number0022066095
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/04/2019
Initial Date Received by Manufacturer 05/20/2019
Supplement Date Received by Manufacturer06/26/2019
Initial Report FDA Received Date05/29/2019
Supplement Report FDA Received Date07/17/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-